Reconsidering the usefulness of using long-acting injectable buprenorphine as a tapering tool: a case report of delayed withdrawal months after last dose

• by Kareem Woods, Sophia Graham, Steven Dobscha, Christopher Blazes

• July 6, 2026

Mechanisms and durability of residential treatment for co-occurring gambling and substance use disorders: a mixed-methods eight-year follow-up study

• by Jonah Im, Sylvia Silver, Fiona Donovan, Aiden Wong, Emma Le, Akul Goel, Ajay Tunikipati, Brad Ruderman, Timothy Fong

• July 6, 2026

Former Dentist Ordered to Pay for Unlawful Prescribing

The judgment stemmed from controlled-substance prescriptions issued after William C. Gardner, DDS, no longer held the state licensure required for federal prescribing authority.

• by Kathryn Wighton

• July 8, 2026

• 2 min

GLP-1 receptor agonists and psychiatric outcomes: a bibliometric analysis of research trends, thematic evolution, and collaboration networks

• by Maria Meritxell Roca Mora, Marcia Sanchez-Monge, Dibe Balardini Ayoub, Ana Beatriz P. Aguiar-Barros, Sofia Serrano-Porras, Renato de Filippis, Georgios Schoretsanitis

• July 21, 2026